In this review, we will discuss multidisciplinary considerations in treating patients with neoadjuvant therapy and highlight areas of controversy and ongoing research.
Melissa Camp, MD, MPH
Advertisement
Articles by Melissa Camp, MD, MPH
Surgery is not obsolete in the management of breast cancer; it is an essential component for almost all patients in the present treatment paradigm.
Advertisement
Latest Updated Articles
- Surgery for Breast Cancer Is Not Obsolete
November 15th 2014
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy
2
Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer
3
FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer
4
FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC
5